HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takeumi Kaneko Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

10/2022Estimating ranibizumab injection numbers and visual acuity at 12 months based on 2-month data on branch retinal vein occlusion treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takeumi Kaneko Research Topics

Disease

3Macular Edema
10/2022 - 07/2021
3Retinal Vein Occlusion
10/2022 - 07/2021
1Vision Disorders (Hemeralopia)
12/2021
1Inflammation (Inflammations)
09/2011
1Fever (Fevers)
09/2011

Drug/Important Bio-Agent (IBA)

3Ranibizumab (Lucentis)FDA Link
10/2022 - 07/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2022
1N-acetyltryptophanamide (NATA)IBA
12/2021
1Proteasome Endopeptidase Complex (Proteasome)IBA
09/2011
1Interleukin-6 (Interleukin 6)IBA
09/2011

Therapy/Procedure

2Lasers (Laser)
12/2021 - 07/2021
1Injections
10/2022
1Therapeutics
12/2021